Genentech Agreement definition

Genentech Agreement means that certain Amended and Restated Non-Exclusive License and Settlement Agreement by and between Regeneron and Genentech, Inc. (“Genentech”), dated May 17, 2013, pursuant to which Genentech granted Regeneron rights to certain Genentech Patents and Regeneron agreed to make certain payments to Genentech relating to certain of Regeneron’s or Company’s sales of EYLEA in the Territory.
Sample 1Sample 2
Genentech Agreement means the Research Agreement by and between Merck and Genentech, Inc. dated as of January 10, 2000. A copy of the Genentech Agreement has been provided to Guilford.
Sample 1
Genentech Agreement means that certain Patent Cross-License Agreement dated September 19, 2002 by and between Genentech Inc. ("Genentech") and Dyax. 
Sample 1

Examples of Genentech Agreement in a sentence

  • Such reimbursements arise in order to ensure that research and development costs are shared equally in-line with the Genentech Agreement.

  • The Parties acknowledge that under such agreements, including the Genentech Agreement, and subject to certain agreements between Roche and Genentech, Roche will have certain rights to participate in the development and commercialization of Anti-IgE Antibody products.

  • Notwithstanding the foregoing, this Agreement shall terminate upon the prior occurrence of the expiration unexercised of any option rights which the Roche Entities may have under the Outline of Terms or Definitive Agreement and the expiration unexercised of any rights which the Roche Entities may have to receive a sublicense or to assume Genentech's rights and obligations under the Genentech Agreement.

  • Additionally, on the Effective Date, Tanox and Genentech have executed the Genentech Agreement which, among other things, grants certain additional license rights to such parties which may be effective in addition to or in lieu of rights under the Outline of Terms and Definitive Agreement.

  • Celtrix agrees that Genzyme may -------------------------- negotiate in its stead or in addition to any efforts made by Celtrix to reduce any royalty payments which may be owed to Genentech under the Genentech Agreement.

  • Licensee acknowledges and agrees that Dyax shall also be permitted to disclose this Agreement in confidence to Affimed, Biosite, CAT, Genentech and XOMA to the extent reasonably necessary to comply with Dyax's obligations pursuant to the Affimed Agreement, Biosite Agreement, CAT Agreement, Genentech Agreement and XOMA Agreement.

  • The Consultant has informed the Company that certain restrictions imposed on him by an existing agreement between Consultant and Genentech (the "Genentech Agreement") affect his ability to be involved with a company developing products which are in direct competition with certain of Genentech's products or to actively recruit employees from Genentech.

  • As disclosed on page F-30 of the Registration Statement, the Company has recorded a receivable of only $200,000 to date under the Merck Agreement, and has not yet recorded or received any amounts under the Genentech Agreement.

  • Signed: /s/ Xxxxx Xxxxxxx Signed: /s/ Xxxxxx Xxxxxxxxxx Name: Xxxxx Xxxxxxx Name: Xxxxxx Xxxxxxxxxx Title: President and CEO Title: Chief Financial Officer Exhibit A [***] Exhibit B [***] Exhibit C [***] Exhibit D Press Release Proteostasis Therapeutics Announces Global License Agreement with Genentech Agreement Covers Small Molecule Modulators of the Cellular Proteostasis Network BOSTON, Mass.

  • Xxxxx shall be solely responsible for the payment of royalty, milestone and other payments due to Third Parties under any agreements between Xxxxx (or its Affiliates) and Third Parties (including the Genentech Agreement) on account of Simcere’s, its Affiliates’ and sublicensees’ Development, Manufacture and Commercialization of the Product in the Field in the Territory.


More Definitions of Genentech Agreement

Genentech Agreement means that certain Exclusive License Agreement between Xxxxx and Genentech, Inc. (“Genentech”), dated October 25, 2016.
Sample 1
Genentech Agreement means that certain Technology Transfer and License Agreement by and between Seller and Genentech, Inc., dated December 13, 2018.
Sample 1
Genentech Agreement means the Non-Exclusive Cabilly Patent License Agreement between Medarex and Genentech, Inc., dated as of October 25, 2004.
Sample 1

Related to Genentech Agreement

  • Research Agreement means a new written contract, grant or cooperative agreement entered into between a person and a college or research corporation for the performance of qualified research; however, all qualified research costs generating a rebate must be spent by the college or research corporation on qualified research undertaken according to a research agreement.

  • Sublicense Agreement means any agreement or arrangement pursuant to which Licensee (or an Affiliate or Sublicensee) grants to any third party any of the license rights granted to the Licensee under the Agreement.

  • License Agreement means the agreement between SAP (or an SAP SE Affiliate, or an authorized reseller) under which Customer procured the rights to use SAP Software or a Cloud Service.

  • Novartis shall have the meaning set forth in the Preamble.

  • Technology License Agreement means the Technology License Agreement dated as of the date hereof between Allergan and ASTI.

  • Software License Agreement means the particular Software License Agreement to which these Terms and Conditions are attached and incorporated into by reference.

  • Merck has the meaning set forth in the preamble.

  • End User License Agreement means a license grant or end user license agreement governing software as further described in this Agreement or any applicable Appendix.

  • Collaboration Agreement has the meaning set forth in the Recitals.

  • Manufacturing Agreement has the meaning set forth in Section 2.6.

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Research License means a nontransferable, nonexclusive license to make and to use the Licensed Products or the Licensed Processes as defined by the Licensed Patent Rights for purposes of research and not for purposes of commercial manufacture or distribution or in lieu of purchase.

  • Supply Agreement has the meaning set forth in Section 7.1.

  • Cross License Agreement means that certain Cross License Agreement between and among Medarex, Cell Genesys, Inc., Abgenix, Inc., Xenotech, L.P. and Japan Tobacco Inc., dated March 26, 1997.

  • ISIS means the department’s individualized services information system.

  • License Agreements shall have the meaning set forth in Section 8.11 hereof.

  • PTI means Preliminary Toxicity Investigation. Up to a 30-day period where the permittee investigates the cause(s) of a whole effluent toxicity exceedance and if the toxicity is known, includes a proposal for its elimination.

  • Sublicensee means a third party to whom LICENSEE grants a sublicense of certain rights granted to LICENSEE under this Agreement.

  • Pfizer shall have the meaning set forth in the preamble.

  • Manufacturing Technology means any and all patents, patent applications, Know-How, and all intellectual property rights associated therewith, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno- associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.

  • Clinical Supply Agreement shall have the meaning set forth in Section 7.2.

  • Third Party Agreement means an agreement with an Underwriting Third Party and/or a Claims Third Party.

  • Licensing Agreement means a commercial agreement between a design approval holder and a production approval holder (or applicant) formalizing the rights and duties of both parties to use the design data for the purpose of manufacturing the product or article.

  • Company License Agreements means any license agreements granting any right to use or practice any rights under any Intellectual Property (except for such agreements for off-the-shelf products that are generally available for less than $25,000), and any written settlements relating to any Intellectual Property, to which the Company is a party or otherwise bound; and the term “Software” means any and all computer programs, including any and all software implementations of algorithms, models and methodologies, whether in source code or object code.

  • Sublicense means any agreement to Sublicense.

  • Shire means Shire of Augusta Margaret River